Surfactant in the preterm infant: what's going on

References

• Soll R F. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000; CD000511
   Google Scholar
• Soll R F. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000; CD001079
   Google Scholar
• Soll R F. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2000; CD001149
   Google Scholar
• Ramanathan R. Choosing a right surfactant for respiratory distress syndrome treatment. Neonatology 2009; 95: 1–5
   PubMed Web of Science ®Google Scholar
• Sinha S K, Lacaze-Masmonteil T, Valls i Soler A, et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 2005; 115: 1030–1038
   PubMed Web of Science ®Google Scholar
• Moya F, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A, Kornacka MK, Merritt TA, Segal R, Schaber CJ, et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome in very preterm infants. Pediatrics 2005; 115: 1018–1029
   PubMed Web of Science ®Google Scholar
• Engle W A. American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008; 121: 419–432
   PubMed Web of Science ®Google Scholar
• Soll R F, Morley C J. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001; CD000510
   Google Scholar
• Bjorklund L J, Ingimarsson J, Curstedt T. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997; 42: 348–355
   PubMed Web of Science ®Google Scholar
• Morley C J, Davis P G, Doyle L W, Brion L P, Hascoet J M, Carlin J B. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700–708
   PubMed Web of Science ®Google Scholar
• Rojas M A, Lozano J M, Rojas M X, Laughon M, Bose C L, Rondon M A, Charry L, Bastidas J A, Perez L A, Rojas C, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized controlled trial. Pediatrics 2009; 123: 137–142
   PubMed Web of Science ®Google Scholar
• Sandri F, Plavka R, Simeoni U. CURPAP Advisory Board. The CURPAP Study: an international randomized controlled trial to evaluate the efficacy of combining prophylactic surfactant and early nasal continuous positive pressure in very preterm infants. Neonatology 2008; 94: 60–62
   PubMed Web of Science ®Google Scholar
• Saugstad O D. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD. Acta Paediatr 1997; 86: 1277–1282
   PubMed Web of Science ®Google Scholar
• Saugstad O D. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003; 8: 39–49
   PubMedGoogle Scholar
• Haagsman H P. Oxidative damage of the pulmonary surfactant system. Semin Neonatol 1998; 3: 207–217
   Google Scholar
• Yeh T F, Lin H C, Chang C H, Wu T S, Su B H, Li T C, Pyati S, Tsai C H. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 2008; 121: e1310–e1318
   PubMed Web of Science ®Google Scholar
• Holm B A, Notter R H, Siegle J, Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985; 59: 1402–1409
   PubMed Web of Science ®Google Scholar
• Nieves-Cruz B, Rivera A, Cifuentes J, Pataki G, Matalon S, Carlo W A, Tanswell A K, Freeman B. Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue. Am J Physiol 1996; 270: L659–L667
   Google Scholar
• Walther F J, David-Cu R, Lopez S L. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am J Physiol 1995; 269: L613–L617
   PubMed Web of Science ®Google Scholar
• Matalon S, Holm B A, Baker R R, Whitfield M K, Freeman B A. Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1990; 1035: 121–127
   PubMed Web of Science ®Google Scholar
• Kribs A, Vierzig A, Hünseler C, Eifinger F, Welzing L, Stützer H, Roth B. Early surfactant in spontaneously breathing with nCPAP in ELBW infants – a single center four year experience. Acta Paediatr 2008; 97: 293–298
   PubMed Web of Science ®Google Scholar
• Trevisanuto D, Grazzina N, Ferrase P, Micaglio M, Verghese C, Zanardo V. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 2005; 87: 217–220
   PubMedGoogle Scholar